Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP)

• Status: Unknown status
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Based on previous results, the investigators considered that sedation quality, complications, and procedure outcomes may not be different, however, propofol alone titration may have a fast recovery time than BPS and cost-effectiveness than balanced propofol sedation (BPS). In present study, the investigators therefore evaluate the time and sedation quality of patient recovery, cost-effectiveness, complication, and procedure outcomes between propofol alone and BPS in therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Soon Chun Hyang University
• Treatments: Propofol

Criteria

Inclusion Criteria:

• candidates for therapeutic ERCP

Exclusion Criteria:

• patient age < 18 years

• pregnant women

• inability to provide informed consent

• patients with total gastrectomy

• American Society of Anesthesiologist (ASA) Class V patients

• patients with known respiratory disease, patients with neurologic impairment

• patients with known allergy to the drugs used, history of complications with previous sedation